HHS looking for a few good health IT privacy specialists

Editorial Staff | | Health Exec | Policy & Regulations

The U.S. Department of Health and Human Services (HHS) Office for Civil Rights is looking to fill its ranks with several health information privacy specialists.

HHS is accepting applications for these fast-tracked positions, which are based in Washington, D.C., through March 12. Pay is at the GS levels of 13-14, with an annual salary range of $89,033 to $136,771.

Some of the duties include: formulating initiatives, projects or proposals and/or improve existing educational programs regarding health information privacy and security of health IT systems, developing materials and strategies to improve program effectiveness, developing and implementing a program design, and providing guidance and advice to senior managers and officials on health privacy matters.

These positions are listed at www.usajobs.gov under the title “Health Information Privacy Specialist,” and the job announcement numbers are HHS-OS-DE-13-846235 and HHS-OS-MP-13-846340.

Editorial Staff

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.